LFST LifeStance Health Group Inc
Price (delayed)
$6.63
Market cap
$2.55B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.15
Enterprise value
$2.87B
Highlights
LFST's EPS has surged by 71% year-on-year and by 42% since the previous quarter
LFST's net income has soared by 69% YoY and by 40% from the previous quarter
Key stats
What are the main financial stats of LFST
Market
Valuations
Earnings
Shares outstanding
384.55M
Market cap
$2.55B
Enterprise value
$2.87B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.75
Price to sales (P/S)
2.01
EV/EBIT
N/A
EV/EBITDA
36.19
EV/Sales
2.3
Revenue
$1.25B
Gross profit
$402.4M
Operating income
-$31.61M
Net income
-$57.44M
EBIT
-$31.08M
EBITDA
$79.37M
Free cash flow
$85.69M
Per share
Balance sheet
Liquidity
EPS
-$0.15
EPS diluted
-$0.15
Free cash flow per share
$0.23
Book value per share
$3.78
Revenue per share
$3.3
TBVPS
$1.67
Total assets
$2.12B
Total liabilities
$672.01M
Debt
$477.94M
Equity
$1.45B
Working capital
$83.62M
Debt to equity
0.33
Current ratio
1.37
Quick ratio
1.25
Net debt/EBITDA
4.07
Margins
Efficiency
Dividend
EBITDA margin
6.3%
Gross margin
32.2%
Net margin
-4.6%
Operating margin
-2.5%
Return on assets
-2.7%
Return on equity
-4%
Return on invested capital
-3.9%
Return on capital employed
-1.6%
Return on sales
-2.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFST stock price
How has the LifeStance Health Group stock price performed over time
Intraday
0%
1 week
0.45%
1 month
-14.89%
1 year
10.68%
YTD
-10.04%
QTD
-0.45%
Financial performance
How have LifeStance Health Group's revenue and profit performed over time
Revenue
$1.25B
Gross profit
$402.4M
Operating income
-$31.61M
Net income
-$57.44M
Gross margin
32.2%
Net margin
-4.6%
The operating margin has surged by 86% year-on-year and by 54% since the previous quarter
The operating income has surged by 83% year-on-year and by 51% since the previous quarter
The net margin has soared by 74% YoY and by 42% from the previous quarter
LFST's net income has soared by 69% YoY and by 40% from the previous quarter
Growth
What is LifeStance Health Group's growth rate over time
Valuation
What is LifeStance Health Group stock price valuation
P/E
N/A
P/B
1.75
P/S
2.01
EV/EBIT
N/A
EV/EBITDA
36.19
EV/Sales
2.3
LFST's EPS has surged by 71% year-on-year and by 42% since the previous quarter
LFST's price to book (P/B) is 2.9% higher than its last 4 quarters average of 1.7
The revenue has grown by 19% YoY and by 3.7% from the previous quarter
Efficiency
How efficient is LifeStance Health Group business performance
LFST's return on sales has surged by 86% year-on-year and by 53% since the previous quarter
LFST's return on invested capital has surged by 82% year-on-year and by 51% since the previous quarter
LifeStance Health Group's return on assets has surged by 69% YoY and by 40% QoQ
LifeStance Health Group's return on equity has surged by 69% YoY and by 40% QoQ
Dividends
What is LFST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFST.
Financial health
How did LifeStance Health Group financials performed over time
The quick ratio has grown by 24% YoY and by 4.2% from the previous quarter
LFST's current ratio is up by 23% YoY and by 3.8% QoQ
The debt is 67% less than the equity
The debt to equity has contracted by 8% YoY and by 2.9% from the previous quarter
The debt has contracted by 6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.